WASHINGTON — A former top official at the Food and Drug Administration and a longtime science journalist are suing the agency and the National Institutes of Health, saying they let clinical trial sponsors off the hook for reporting nearly a decade’s worth of important scientific data.
Under a law passed in 2007, researchers involved in many clinical trials must report their results to the federal government. But the NIH and FDA only finalized a rule to ensure compliance in 2016.
Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!
GET STARTEDWhat is it?
STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.
What's included?
- Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
- Subscriber-only networking events and panel discussions across the country
- Monthly subscriber-only live chats with our reporters and experts in the field
- Discounted tickets to industry events and early-bird access to industry reports
About the Author
This is what we get, when we allow a criminal to appoint industry insiders and people of low moral character to our federal agencies. These agencies are still understaffed, and key positions have been cut or left unfilled. These agencies have been undermined by design, in order to allow groups like PhRMA to continue their illegal activities.
All I am say that thanks for all you have done!
Comments received by the FDA on its plans show that patients, doctors and scientists overwlehmingly support the imposition of fines, across the board. Only PhRMA and AdvaMed are opposed:
https://www.transparimed.org/single-post/2018/12/07/Pharma-and-medical-device-lobbies-stonewall-on-transparency-as-doctors-and-patients-call-for-fines-on-companies-hiding-clinical-trial-results